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Electrospray mass s~trometry of the purified isoforms of the hypusine-containing protein of ~ucc~ro~yces cerevisiae HypZp suggested a 
phospho~lation of the acidic isoform, which was confirmed by phosphatase treatment. The phospho~lation site was mapped to the N-acetylated 
se&e residue in position no. 1 by mass spectrometric analysis of enzymatic fragments. Mutation of this serine residue gives rise to only the basic 
isoform, confirming our protein chemical data. As this mutation has no effect on cell viability or growth rate. the unphosphorylated isoform is 
sufficient o exert the essential in vivo function of Hyp2p. 
eIF-5A; Isoform: Phosphorylation; Acetylation: Amino terminus; Yeast 
1. I~RODUCTION product of 18 kDa) detected under aerobic conditions 
are HYP2 gene products [9]. 
The hypusine-containing protein is so far the only 
known protein, in which a specific lysine residue is mod- 
ified by the aminobutyl moiety of the polyamine sper- 
midine. Subsequent hydroxylation of this deoxyhypu- 
sine residue results in the unique amino acid hypusine 
[l]. The protein with its hypusine modification is highly 
conserved in all eukaryotes (for review see 121) and was 
also found in archaebacteria [3,4], but not in eubacteria. 
Functional analysis in the methionyl puromycin assay 
suggested a role of this protein in the first peptide bond 
formation. Therefore, it was originally designated 
eukaryotic translation initiation factor 5A (eIF-5A) [S]. 
Nevertheless, very little is known about its function in 
vivo (for review see [2]). 
In order to gain some insight into the cellular func- 
tion of the hypusine-containing protein and the regula- 
tion of its activity, we purified the two aerobically ex- 
pressed isoforms and the degradation product and ana- 
lyzed their structure in detail. 
2. MATERIALS AND METHODS 
2.1. Purtf?catlon of the Hyp2p isoformr 
In the budding yeast Saccharomyces cerevisiae the 
hypusine-containing protein is encoded by two highly 
homologous genes, one of which is under strict anaero- 
bic control (HYPZ = ANBI = TIFSlB, [68]). In con- 
trast, the transcription of the HYP2 gene ( = TZF5IA) 
is positively controlled by oxygen and heme. Gene dis- 
ruption analysis showed that under aerobic conditions 
HYPE expression is essential for viability in yeast 191. 
All three forms of the hypusine-containing protein (two 
isoforms of 21 kDa and a degradation or processing 
Subsequent to the isolation procedure of the Hyp2p [9], the isoforms 
were separated on an anion exchange HPLC (Aquapore Anion 100 
x 2.1 mm, 7.1 pm; Applied Biosystems), which was eluted with 50 
mM sodium phosphate (flow rate 0.5 mllmin) with a gradient of 
2~300 mM NaCl in 5 min and 30@600 mM NaCi in 30 min. For 
mass spectrometry, the isoforms were re~hromatograph~ on a 
Vydac C,* reversed-phase HPLC in a gradient of 1@30% acetonitrilel 
0.1% trifluoroacetic acid in 10 min and 30-60% acetonitrile/O. 1% tri- 
fluoroacetic acid in 30 min. 
2.2. Mass spectrometry 
The reversed-phase HPLC fractions were delivered to the sprayer 
of the atmospheric pressure ionisation source, connected to the tan- 
dem quadrupole instrument API III (Sciex, Tho~hill, Ontario, Can- 
ada), with a flow rate of 5 ,&min by a syringe infusion pump (Model 
22, Harvard Apparatus, South Natick. USA). The instrument m/z 
scale was calibrated with ammonium adduct ions of polypropylene 
glycol. The average molecular masses of the peptides were calculated 
from the m/z peaks of the charge distribution profiles of the multiply 
charged ions [lO,ll]. 
*Corresponding author. Fax: (49) (89) 8578 2802. 
2.3. Alkaline phosphatas~ treatment 
Abbrev~fions: HPLC, high-performs liquid chromatography~ The isoforms were precipitated in 10% t~chloroa~tic acid (w/v) on 
Hyplp, gene product of HYPI = ANB 1 = TIF51B; Hyptp, gene ice for 30 min. After ~nt~fugation (16,~ x g/4*Cll5 mink the pellet 
product of HYP2 = TIF5iA; hyp2, disrupted HYP2 gene; IEF, isoe- was washed with ice-cofd aceton, centrifuged. air dried and dissolved 
lectric focussing; p1, isoelectric point; SDS-PAGE, sodium dodecyl in 100 ~1 50 mM Tris-HCl, 0.1 mM EDTA, pH 8.5. After incubation 
sulfate-polyacrylamide g l electrophoresis. for 1 h at 37OC with 0.1 unit calf intestine phosphatase (Boehringer, 
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FRG) per .ug protein [12], the samples were precipitated as described 
above. 
2.4. Enzymatic cleavage 
For tryptic digestion, the isoforms were precipitated as described 
above, resuspended in 100 ,!d 0.1 M Tris-HCl pH 8.0 and incubated 
with 0.025 pg trypsin per mg protein at 37°C. The same amount of 
trypsin was added after 2.5 h and 5 h. After 8 h the reaction was 
stopped with 1% trifluoroacetic acid. Peptides were separated on a 
Supersphere RP60 Select B reversed-phase HPLC column (125 x 2 
mm/4 pm; Merck, FRG) using a linear gradient of O-60% acetonitrile 
in 0.1% t~fluoroa~tic acid at a flow rate of 0.3 mllmin. 
Further cleavage of the N-terminal peptide with endoproteinase 
Glu-C (Boehringer, FRG) was performed in 50 mM ammonium ace- 
tate pH 4.0 with 0.05 fig endoproteinase G1u-C per Bg protein for 20 
h at room temperature. Peptides were isolated as described above. 
2.5. Miscellaneous methods 
Two-dimensional gels (isoelectric focussing on immobilized pH gra- 
dients and SDS-PAGE) and Western blots were performed according 
to [13] using a 1:250 dilution of the crude a-Hyp2p ~ly~lonal anti- 
body and a I:4000 dilution of the alkaline phosphatase coupled a- 
chicken IgG (Sigma, St. Louis). 
O~ho-phth~diaidehyde ammo acid analysis was performed as de- 
scribed earlier [9]. For amino acid sequence analysis an Applied Bio- 
systems 477A gas phase sequencer connected with a 12OA PTH amino 
acid analyzer was used according to the manufacturer’s instructions. 
2.6. Construction of GALIIHYPZ fusion genes 
PCR amplification was used to clone the coding region of the wild- 
type gene HYP;’ and the mutated HYPZ[Alal J as a 480 bp BamHIf 
XbaI fragment into pRSGAL, which is a single-copy plasmid contain- 
ing the yeast GAL.1 promoter [9]. The strategy for the design of the 
primers, amplification and cloning of the PCR products was described 
previously 1141. The olig~eox~ucleotide used for the construction of 
pRSG-H~2[Alal] led to a change of the triplet immediately follow- 
ing the ATG startcodon from TCT (coding for se&e) in the wild-type 
gene to GCT (coding for alanine). The sequence of the cloned PCR 
fragment was verified by DNA sequence analysis [LS]. Tr~sfo~ation 
of pRSG-HYP2 or pRSG-HY~[~al] into yeast was performed ac- 
cording to [16]. Yeast cells were either grown on semisynthetic medium 
(with 3% galactose or 2% glucose) or yeast peptone dextrose (YPD) 
and yeast peptone galactose (YPGal) media, respectively [17]. 
3. RESULTS AND DISCUSSION 
Under aerobic conditions two isoforms and a degra- 
dation product thereof, lacking the first ten amino 
acids, were identified as gene products of HYP2 [9]. As 
a basis for investigating the in vivo function of the 
Hyp2p forms, we now analyzed their protein chemical 
structure in detail. In the final pu~fication step, which 
separates these three proteins, the degradation product, 
the basic and the acidic isoform eluted from the anion 
exchange HPLC at 420-450 mM NaCl, 460490 mM 
NaCI, and 520-580 mM NaCl, respectively (Fig. 1). The 
purified proteins were subjected to mass spectrometry. 
Electrospray mass spectrometric analysis of the deg- 
radation product revealed a mass of 15,921.g + 1.9 Da. 
This value matches the average molecular mass deduced 
from the amino acid sequence including the hypusine 
modification (15,922.17 Da). Also the mass of the basic 
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Fig. 1. Chromatogram of the separation of the Hyp2p forms by anion exchange HPLC. The insert shows a schematic two-dimensional gel of the 
Hyp2p. Correspondence of the protein spots with the absorption peaks together with the respective determined molecular masses of the three Hyp2p 
forms is indicated by connecting fines. 
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isoform of 17,112.B ? 1.9 Da matches the calculated 
value of 17,111.33 Da (without the N-terminally en- 
coded methionine, but including the hypusine-modifica- 
tion and the N-terminal acetylation). Consequently, 
also this isoform carries no further modification. In 
contrast, the mass of the acidic isoform (17,192.7 ? 1.1 
Da) is about 80 Da higher than the determined molecu- 
lar mass of the basic isoform. This led to the conclusion, 
that the acidic isoform is additionally modified either by 
sulfatation or by phosphorylation (mass difference of 
80.06 Da or 79.08 Da, respectively). 
By treatment of a Hyp2p preparation (without prior 
separation of the isoforms) with calf intestine phosphat- 
ase the acidic isoform disappears, whereas the amount 
of the basic isoform profoundly increases (Fig. 2). The 
degradation product does not shift in position or inten- 
sity (not shown). By this result the additional modifica- 
tion of the acidic isoform is identified as a phosphoryl- 
ation. Also the mass spectrometric data that neither the 
degradation product nor the basic isoform are 
phosphorylated are confirmed. 
For identification of the phosphorylation site, the 
tryptic fragments of the Hyp2p acidic isoform were iso- 
lated by reversed-phase HPLC and identified by amino 
acid analysis (data not shown) and mass spectrometry. 
With the exception of the N-terminal fragment, the mo- 
lecular masses of all other fragments were in good 
agreement with the calculated values. The N-terminal 
fragment T, from serine in position no. 1 to arginine in 
position no. 26 (Fig. 3) was identified by amino acid 
analysis and the fact that this fragment is blocked to 
direct N-terminal sequencing. The molecular mass of 
this peptide differs from the calculated mass (2847.91 
Da) by about 80 Da (determined mass: 2926.5 ? 0.2 
Da). As this difference in molecular weight was also 
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Fig. 2. Silver stained two dimensional gel of 2 fig of Hyp2p isoforms 
before (A) and after (B) treatment with calf intestine phosphatase, 
which leads to the loss of the acidic isoform and concomitant increase 
of the basic isoform. The pH gradient of the isoelectric focussing in 
the first dimension is indicated on top. 
found for the intact isoforms, the phosphorylation, 
which generates the acidic isoform, must be located 
within this N-terminal tryptic peptide. 
In order to distinguish between the different possible 
phosphorylation sites, we further digested the N-termi- 
nal tryptic fragment of the acidic isoform with endopro- 
teinase Glu-C, an enzyme cleaving glutamyl bonds. The 
expected and obtained fragments are shown in Fig. 3. 
Fragment E4 yielded a mass of 1829.7 f 0.7 Da (calcu- 
lated mass: 1830.04 Da), leading to the conclusion that 
the site of the phosphorylation lies within the remaining 
eight N-terminal amino acid residues. The mass of 
661.4 f 0.3 Da corresponds to peptide E,, and thus 
excludes the threonine residue in position no. 6 as the 
phosphorylation site. In contrast, the peptide E,_, 
yielded a mass of 1115.5 + 0.9 Da, which again lies 
about 80 Da above the calculated mass of 1035.91 Da 
(including the acetylation on the fist serine residue). 
Fragment E, was not detected, presumably, because it 
elutes in the flow through of the reversed phase HPLC, 
which was not analyzed due to its high salt concentra- 
tion. These data clearly map the phosphorylation to the 
first serine residue. Thus in the acidic isoform the N- 
terminal serine residue is both acetylated and 
phosphorylated. To our knowledge, this type of double 
modification of the N-terminus has not been described 
so far. 
This result was also confirmed by direct N-terminal 
sequencing of the Hyp2p isoforms prepared from the 
AMR 1 ( = W303-1A natl-5) strain of Saccharomyces 
cerevisiue, which is deficient in the N-terminal acetyl 
transferase Natlp [18]. The Hyp2p isoforms prepared 
from this strain are not N-terminally acetylated and are 
thus accessible to Edman degradation, as we published 
earlier [9]. Sequence analysis of both isoforms showed 
a serine residue in position no. 1, but the conversion of 
serine to its B-elimination product dehydroalanine was 
almost quantitative in the acidic isoform. This strongly 
supports a modification of this residue [19]. 
The acetylation does not contribute to the essential 
function of the Hyp2p, as can be seen by the viability 
of the AMR 1 strain. To investigate whether the 
phosphorylated form of Hyp2p is essential for the in 
vivo function, we expressed a Hyp2p carrying a serine-1 
to alanine-l mutation in yeast and tested, if it is able to 
complement a hyp2 disruption devoid of endogenous 
wild-type Hyp2p. For this purpose, the following plas- 
mid shuffle experiment was employed: a haploid hyp2 
mutant strain containing the wild-type HYP2 gene 
under the control of its own promoter on a multi-copy 
plasmid [9] was transformed with the centromere plas- 
mid pRSG-HYP2[Alal] or pRSG-HYP2 producing ei- 
ther the mutant protein HYP2[Alal]p or the wild-type 
Hyp2p, respectively. The multi-copy vector YEp-HYP2 
harbors the URA3 gene, the centromeric pRSG-derived 
plasmids contain the HIS3 gene as a selective marker. 
The yeast double transformants were then grown in 
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Fig. 3. Schematic representation of the peptides (E,_,, E2+3, I&) obtained from digestion of the N-terminal tryptic peptide T, with endoproteinase 
Glu-C. Their dete~ined and calculated (in brackets) molecular masses are given above and below the schematic peptide drawings, respectively. 
non-selective medium with galactose as the carbon 
source for five days (medium change every 36 h). Under 
such conditions, a spontaneous loss of a non-essential 
plasmid is likely to occur due to its mitotic instability 
f20J. In contrast, a plasmid encoding an essential func- 
tion should be strictly retained. The double transfor- 
mant strain containing YEp-HYP2 and pRSG-HYP2 
retained the tJR93 marker in 53% and the HLS3 marker 
in 68% of the tested cells. A very similar result was 
obtained with the strain transformed with pRSG- 
HYP2[Alal] instead of pRSG-HYP2 (58% URA3 / 69% 
HJS3). In both cases, a simultaneous loss of both plas- 
mids in any single cell was never observed, underlining 
the essential function of Hyp2p under aerobic condi- 
tions. When the same experiment was performed with 
glucose as the carbon source (under these conditions the 
transcription of the pRSG-encoded GAL~~~~P~ fusion 
genes is repressed, whereas the synthesis of Hyp2p en- 
coded by YEp-HYP2 is carbon source-independent), 
the YEp-HYP2 plasmid was strictly retained in both 
cases, but the HIS3 marker was again lost with high 
frequency. Since in both strains the rate of spontaneous 
loss of either the YEp-HYP2 or the pRSG-derived plas- 
mids was comparable with galactose as the carbon 
source, we conclude that the wild-type Hyp2p and the 
mutant protein Hyp2[Alal]p are functionally equivalent 
in vivo. This result was further confirmed by measuring 
the growth rates in liquid medium. hypl! mutant strains, 
only expressing either EIYP2 or ~Y~~~A~Q~~ under the 
control of the GAL1 promoter reveal almost identical 
doubling rates in galactose complete medium. 
By two-dimensional Western blot analysis of soluble 
cellular protein extracts we finally checked the isoform 
pattern of the strain carrying the mutant pRSG- 
HYP2[Alal] in comparison with the strain comple- 
mented with the wild-type pRSG-HYP2. As is clearly 
shown in Fig. 4, two isoforms and the degradation 
product can be detected in the pRSG-HYP2 containing 
strain. As expected, the extracts of the pRSG- 
HYP2{Alal] mutant contain only one isoform of 
Hyp2p, which was identified as the basic isoform by its 
relative position in silver stained two dimensional gels 
(not shown). A degradation product was hardly detect- 
able in this strain (Fig. 4). These data obtained from in 
vivo experiments confirm our mapping of the phospho- 
rylation site to the serine residue in position no. 1. Fur- 
thermore, the perfect viability of the cells devoid of the 
acidic isoform of the Hyp2p clearly demonstrates that 
the basic isoform alone is suffzient to fulfill the essential 
function of this protein in vivo. 
During the preparation of this manuscript, Kang et 
al [21] also published the isolation of the Hyp2p 
isoforms by Mono S/Mono Q ion exchange chroma- 
tography, confirming our observation that more acidic 
than basic isoform could be obtained. This is in line with 
the in vivo labeling data presented by Kang et al. [21] 
that the progression of the basic to the acidic isoform 
is very rapid with a half-life of about 15 min for the 
basic isoform. 
By in vivo phosphorylation and thin-layer chroma- 
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Fig. 4. Two~imensional Western blot of total soluble extract from the 
strain carrying the pRSG-HYP2 (A) or the pRGSHYP2[Alal] plas- 
mid (I%)_ The cells expressing the wild-type HYP2 gene show two 
isoforms @I = 4.76 and p1 = 4.85) and a degradation product 
(pl = 5.28) thereof. In contrast, in extracts from cells expressing the 
mutated gene HYP2fMalf no acidic isoform and only very little 
degradation product is detectable. The pH gradient of the isoelectric 
focussing in the first dimension is indicated on top. 
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tography of total amino acid hydrolysates, these au- 
thors were able to characterize the isoform difference as 
a serine phosphorylation. In addition to the identifica- 
tion of this phosphorylation, we were further able to 
locate its site to the serine residue in position no. 1 of 
the acidic isoform by amino acid sequence and compo- 
sition analysis and mass spectrometry of the Hyp2p 
forms and their enzymatic fragments. Since the N-ter- 
minus of the Hyp2p is in addition blocked by acetyla- 
tion [9], the double modification of this residue is beside 
the hypusine modification another odd and possibly 
unique feature of the Hyp2p. A modification of the 
threonine residue no. 48 was proposed for the hypusine- 
containing protein of CHO cells [22,23]. As the only 
observed deviation of the determined masses of the 
Hyp2p isoforms and their enzymatic fragments from 
the calculated values is explained by the phosphoryla- 
tion of the first serine residue, this clearly excludes fur- 
ther modifications of these purified Hyp2p isoforms in 
this strictly conserved threonine-48 or any other part of 
the molecule. 
Kang et al. [21] failed to detect the third more basic 
and smaller Hyp2p form, which we identified as a deg- 
radation product [9], in detergent free cellular extracts. 
In contrast to that we found this degradation product 
in all extracts of aerobically grown cells independent 
from procedure, buffer composition or use of detergent 
([9,13], Magdolen et al. manuscript in preparation]). In 
addition, we showed that under identical experimental 
conditions extracts of the HYP2[Alul] expressing 
strain, which produces no acidic isoform, contain less 
degradation product than extracts of the wild-type 
HYP2 expressing strain. Therefore we consider the deg- 
radation product as a naturally occurring in vivo form, 
the concentration of which might depend on the amount 
of the acidic isoform. Nevertheless, more degradation 
product can be obtained after cell lysis, if protease inhi- 
bition is insufficient. Further functional analysis of this 
degradation/processing product is in preparation. Since 
we finally demonstrated by mutation of the N- terminal 
serine residue to alanine that the basic (unphosphor- 
ylated) isoform alone can carry out the essential func- 
tion of the Hyp2p in vivo, it is tempting to speculate that 
the phosphorylation might result in an inactivation of 
the protein or even tag the protein for degradation. 
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